KAI Biotech (XKON:A446600) - Stock Price, News & Analysis

A446600 Stock Overview

Manufactures and sells radiopharmaceuticals, dementia diagnosis drugs, and liver cancer treatment drugs. More details

A446600 fundamental analysis
Snowflake Score
Valuation	0/6
Future Growth	0/6
Past Performance	0/6
Financial Health	0/6
Dividends	0/6

Risk Analysis

Does not have a meaningful market cap (₩6B)

Has not reported any financial data

Shares are highly illiquid

KAI Biotech Co., LTD. Competitors

Union Korea Pharm

KOSDAQ:A080720

₩15.4b

ADBiotech

KOSDAQ:A179530

₩26.6b

WooGene B&G

KOSDAQ:A018620

₩27.5b

ChoA Pharmaceutical

KOSDAQ:A034940

₩30.1b

Price History & Performance

Summary of all time highs, changes and price drops for KAI Biotech
Historical stock prices
Current Share Price	₩6,400.00
52 Week High	₩18,700.00
52 Week Low	₩6,340.00
Beta	0
11 Month Change	n/a
3 Month Change	n/a
1 Year Change	n/a
33 Year Change	n/a
5 Year Change	n/a
Change since IPO	-70.91%

Recent updates

Shareholder Returns

	A446600	KR Pharmaceuticals	KR Market
7D	0%	-9.2%	-2.8%
1Y	n/a	8.0%	-3.4%

Return vs Industry: Insufficient data to determine how A446600 performed against the KR Pharmaceuticals industry.

Return vs Market: Insufficient data to determine how A446600 performed against the KR Market.

Price Volatility

Is A446600's price volatile compared to industry and market?
A446600 volatility
A446600 Average Weekly Movement	n/a
Pharmaceuticals Industry Average Movement	5.5%
Market Average Movement	5.7%
10% most volatile stocks in KR Market	11.5%
10% least volatile stocks in KR Market	2.7%

Stable Share Price: A446600's share price has been volatile over the past 3 months compared to the KR market.

Volatility Over Time: Insufficient data to determine A446600's volatility change over the past year.

About the Company

Founded	Employees	CEO	Website
n/a	n/a	Kim Young-Deok	www.kaibiotech.com

KAI Biotech Co., LTD. manufactures and sells radiopharmaceuticals, dementia diagnosis drugs, and liver cancer treatment drugs. The company is based in Jeonju, South Korea.

KAI Biotech Co., LTD. Fundamentals Summary

How do KAI Biotech's earnings and revenue compare to its market cap?
A446600 fundamental statistics
Market cap	₩6.28b
Earnings (TTM)	₩0
Revenue (TTM)	n/a

n/a

P/E Ratio

n/a

P/S Ratio

Is A446600 overvalued?

See Fair Value and valuation analysis

Earnings & Revenue

Key profitability statistics from the latest earnings report (TTM)
A446600 income statement (TTM)
Revenue	₩0
Cost of Revenue	₩0
Gross Profit	₩0
Other Expenses	₩0
Earnings	₩0

Last Reported Earnings

n/a

Next Earnings Date

n/a

Earnings per share (EPS)	0
Gross Margin	0.00%
Net Profit Margin	0.00%
Debt/Equity Ratio	0.0%

How did A446600 perform over the long term?

See historical performance and comparison

KAI Biotech XKON:A446600 Stock Report